Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
Q9TP11
|
MHC lymphocyte antigen; Fragment;
|
HLA-G;
|
NULL
|
24
|
human
|
A8K657
|
cDNA FLJ77313;
|
NULL
|
NULL
|
206
|
human
|
A6YXS6
|
ATP synthase subunit a;
|
ATP6;
|
NULL
|
226
|
human
|
J3QSY6
|
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;
|
ATP2A2;
|
NULL
|
50
|
human
|
Q000Z0
|
MHC class I antigen; Fragment;
|
HLA-B;
|
NULL
|
181
|
human
|
Q05C86
|
SMYD2 protein; Fragment;
|
SMYD2;
|
NULL
|
417
|
human
|
J3QTB0
|
Short transient receptor potential channel 3;
|
TRPC3;
|
NULL
|
793
|
human
|
Q2HY01
|
MHC class I antigen; Fragment;
|
HLA-B;
|
NULL
|
181
|
human
|
Q19Q54
|
Cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 mutant; Fragment;
|
CFTR;
|
NULL
|
61
|
human
|
A8K2S4
|
cDNA FLJ76779, highly similar to Homo sapiens MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 1, mRNA;
|
NULL
|
NP_059672.2;
|
745
|
human
|
Q86YG9
|
Similar to glucagon-like peptide 1 receptor; Fragment;
|
NULL
|
NULL
|
409
|
human
|
Q19UG3
|
Coagulation factor IX; Fragment;
|
F9;
|
NULL
|
182
|
human
|
J3KMZ0
|
Homeobox protein Hox-C11;
|
HOXC11;
|
NULL
|
378
|
human
|
A7VN07
|
Epidermal growth factor receptor; Fragment;
|
EGFR;
|
NULL
|
27
|
human
|
A5PLN4
|
Splicing factor 4;
|
SF4;
|
NULL
|
645
|
human
|
A8MUN2
|
Apolipoprotein B-100;
|
APOB;
|
NULL
|
828
|
human
|
A9Z188
|
MHC class I antigen; Fragment;
|
HLA-A;
|
NULL
|
181
|
human
|
Q59FY5
|
Brefeldin A-inhibited guanine nucleotide-exchange protein 1 variant; Fragment;
|
NULL
|
NULL
|
1278
|
human
|
E5RGH0
|
Zinc finger protein 721;
|
ZNF721;
|
NULL
|
61
|
human
|
B1Q3B3
|
Ferritin; Fragment;
|
FTL;
|
NULL
|
92
|
human
|